Physician

Christopher J Gamard, M.D.

According to 2025 Medicare claims, Christopher Gamard, M.D. (NPI: 1215984786) practices internal medicine in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is IMC-DIAGNOSTIC AND MEDICAL CLINIC LLC (NPI: 1447201066; TIN: 631012832) and primary practice location at 36604-1416. Gamard is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535), participating under the MSSP model.

Gamard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 608 traditional Medicare patients, billed 12,085 HCPCS/CPT codes, and received $284,297 in Medicare payments. The top billing code was 84443 (Blood test, thyroid stimulating hormone (tsh)). Part D data shows 20,959 prescription claims across 1,341 beneficiaries totaling $1,843,868 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 60 claims. Open Payments data shows 92 records totaling $1,415. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,149,272 to $1,843,868. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $21,655 and ending at $14,613.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,165	17,903	$238,505
2016	1,130	13,742	$251,274
2017	892	10,242	$214,044
2018	841	12,429	$223,124
2019	800	10,414	$231,133
2020	701	8,966	$202,071
2021	683	9,303	$222,757
2022	638	10,094	$209,431
2023	631	10,410	$235,860
2024	608	12,085	$284,297

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,267	20,272	$1,149,272
2016	1,315	20,424	$1,176,471
2017	1,313	19,725	$1,208,030
2018	1,299	19,061	$1,287,970
2019	1,292	18,942	$1,376,693
2020	1,270	19,083	$1,399,326
2021	1,275	19,382	$1,360,561
2022	1,272	19,304	$1,514,507
2023	1,274	19,863	$1,825,321
2024	1,341	20,959	$1,843,868

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	152	602	$17,668
2016	129	554	$13,221
2017	46	297	$10,701
2018	50	334	$13,388
2019	28	214	$12,159
2020	18	245	$13,626
2021	15	155	$16,500
2022	19	214	$17,910
2023	12	267	$25,629
2024	N/R	60	$18,793

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
84443	Blood test, thyroid stimulating hormone (tsh)	415	554	$16
80053	Blood test, comprehensive group of blood chemicals	437	629	$10
84439	Thyroxine (thyroid chemical), free	413	549	$9
36415	Insertion of needle into vein for collection of blood sample	441	712	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	430	618	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	226	7,064	$265,517
Eliquis	Apixaban	204	10,143	$191,018
Ozempic	Semaglutide	184	5,958	$184,761
Jardiance	Empagliflozin	108	6,783	$133,860
Farxiga	Dapagliflozin Propanediol	110	5,340	$100,333

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	17	$9,328
B4153	Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$6,511
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	20	$1,877
A4407	Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each	N	N/R	11	$1,077

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	92	$1,415	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher J. Gamard, M.D.?

Tedicare shows public-source Medicare data for Christopher J. Gamard, M.D. (NPI 1215984786), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher J. Gamard, M.D. have ACO affiliation data?

Christopher J. Gamard, M.D. is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535).

What billing organization is linked to Christopher J. Gamard, M.D.?

Christopher J. Gamard, M.D. is linked to IMC-DIAGNOSTIC AND MEDICAL CLINIC LLC (billing NPI 1447201066) in the available physician profile data.

Does Christopher J. Gamard, M.D. have Open Payments data?

Christopher J. Gamard, M.D. has 92 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.